Risk factors, presentation and outcome of meningomyelocele repair

Lal Rehman, Munwar Shiekh, Ali Afzal, Raza Rizvi, Lal Rehman, Munwar Shiekh, Ali Afzal, Raza Rizvi

Abstract

Objective: To determine the risk factors, presentation and outcome of meningomyelocele repair.

Methods: We reviewed 150 cases operated for meningomyelocele (MMC) at Jinnah Postgraduate Medical Centre Karachi between May 2015 and May 2018. Data of infants operated for MMC repair was extracted including socioeconomic status, maternal folate intake during pregnancy, head circumference, location and width of the defect, accompanying bladder and limb anomalies and treatments administered. Patients were followed up for a mean period of six months.

Results: A total of 150 children were evaluated, out of which there were 83(55.3%) males and 67(44.7%) females. All belonged to low socio economic group and prenatal maternal folate intake as risk factor was positive in 103(68.7%) cases. Mean head circumference was 37.4 cm (range, 30.7 to 50 cm). Based on their location, 83(55%) of the defects were lumbosacral, 38(25.4%) were lumbar, 16(10.7%) were thoraco lumbar, 10(6.7%) were thoracic and three (2%) were cervical. Mean size of the meningomyelocele sac was 4.3 cm×5.6 cm (range, 1cm×2 cm to 11cm×8.4cm) and 21(14%) of the babies had a skin defect requiring flap. According to accompanying anomalies, 98(65.3%) of the babies had hydrocephalus, 13(9%) had club foot, four (2.7%) had diastematomyelia and three (2%) had tethered cord. Eighty seven (58%) patients had neurological deficit pre operatively and eight (5.4%) patients with normal power deteriorated after surgery out of which five (3.3%) developed paraplegia and three (2%) developed paraparesis. CSF leak was the major complication encountered in 16(11%) followed by meningitis in seven (5%), while the overall mortality was four (2.6%).

Conclusion: The practice of periconceptional folic acid supplementation is essential to reduce the prevalence of neural tube defects (NTDs) in the developing world. Improved maternal nutrition with access to quality antenatal care is vital to decrease the prevalence and health burden.

Keywords: MMC repair; Maternal folate intake; Meningomyelocele; Neural Tissue.

Copyright: © Pakistan Journal of Medical Sciences.

Figures

Fig.1
Fig.1
Location.
Fig.2
Fig.2
Associated Anomalies.

References

    1. Lien SC, Maher CO, Garton HJ, Kasten SJ, Muraszko KM, Buchman SR. Local and regional flap closure in myelomeningocele repair:a 15-year review. Childs Nerv Syst. 2010;26:1091–1095. doi:10.1007/s00381-010-1099-9.
    1. Khattak ST, Khan M, Naheed T, Khattak Iu, Ismail M. Prevalence and management of anencephaly at Saidu Teaching Hospital, Swat. J Ayub Med Coll Abbottabad. 2010;22(4):61–63.
    1. Qazi G. Relationship of selected prenatal factors to pregnancy outcome and congenital anomalies. J Ayub Med Coll Abbottabad. 2010;22:41–45.
    1. Kankaya Y, Sungur N, Aslan OC, Ozer K, Ulusoy MG, Karatay M, et al. 'Alternative method for the reconstruction of meningomyelocele defects:V-Y rotation and advancement flap. J Neurosurg Pediatr. 2015;15:467–474. doi:10.3171/2014.12.PEDS14133.
    1. Liptak GS, Dosa NP. Myelomeningocele. Pediatr Rev. 2010;31:443–450. doi:10.1542/pir.31-11-443.
    1. Mehta VA, Bettegowda C, Amin A, El-Gassim M, Jallo G, Ahn ES. Impact of tethered cord release on symptoms of Chiari II malformation in children born with a myelomeningocele. Childs Nerv Syst. 2010;27(6):975–978. doi:10.1007/s00381-010-1294-8.
    1. Onrat ST, Seyman H, Konuk M. Incidence of neural tube defects in Afyonkarahisar, Western Turkey. Genet Mol Res. 2009;8:154–161.
    1. Wald NJ, Morris JK, Blakemore C. Public health failure in the prevention of neural tube defects:time to abandon the tolerable upper intake level of folate. Public Health Rev. 2018;39:2. doi:10.1186/s40985-018-0079-6.
    1. Salih MA, Murshid WR, Seidahmed MZ. Epidemiology prenatal management, and prevention of neural tube defects. Saudi Med J. 2014;35(Suppl 1):S15–28.
    1. Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, et al. Describing the Prevalence of Neural Tube Defects Worldwide:A Systematic Literature Review. PLoS One. 2016;11(4):e0151586. doi:10.1371/journal.pone.0151586.
    1. Gedefaw A, Teklu S, Tadesse BT. Magnitude of Neural Tube Defects and Associated Risk Factors at Three Teaching Hospitals in Addis Ababa, Ethiopia. Biomed Res Int. 2018;2018:4829023. doi:10.1155/2018/4829023.
    1. Khan A. Outcome of Myelomeningocele Repair and Early Post-operative Complications. Pak J Neurol Surg. 2018;22(4):200–205.
    1. Tarcan T, Onol FF, Ilker Y, Alpay H, SimSek F, Ozek M. The timing of primary neurosurgical repair significantly affects neurogenic bladder prognosis in children with myelomeningocele. J Urol. 2006;176(3):1161–1165.
    1. Oncel MY, Ozdemir R, Kahilogulları G, Yurttutan S, Erdeve O, Dilmen U. The effect of surgery time on prognosis in newborns with meningomyelocele. J Korean Neurosurg Soc. 2012;51(6):359–362. doi:10.3340/jkns.2012.51.6.359.
    1. Marreiros H, Loff C, Calado E. Who needs surgery for pediatric myelomeningocele?A retrospective study and literature review. J Spinal Cord Med. 2015;38(5):626–640. doi:10.1179/2045772314Y.0000000229.
    1. Adzick NS, Thom EAx, Spong CY, Brock JW, 3rd, Burrows PK, Johnson MP, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993–1004. doi:10.1056/NEJMoa1014379.
    1. Kshettry VR, Kelly ML, Rosenbaum BP, Seicean A, Hwang L, Weil RJ. Myelomeningocele:surgical trends and predictors of outcome in the United States 1988-2010. J Neurosurg Pediatr. 2014;13(6):666–678. doi:10.3171/2014.3.PEDS13597.
    1. Shim JH, Hwang NH, Yoon ES, Dhong ES, Kim DW, Kim SD. Closure of Myelomeningocele Defects Using a Limberg Flap or Direct Repair. Arch Plast Surg. 2016;43(1):26–31. doi:10.5999/aps.2016.43.1.26.
    1. Dupepe EB, Hopson B, Johnston JM, Rozzelle CJ, Jerry Oakes W, Blount JP, et al. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele. Neurosurg Focus. 2016;41(5):E6. doi:10.3171/2016.8.FOCUS16257.
    1. Pinto FC, Matushita H, Furlan AL, Alho EJ, Goldenberg DC, Bunduki V, et al. Surgical treatment of myelomeningocele carried out at 'time zero'immediately after birth. Pediatr Neurosurg. 2009;45:114–118. doi:10.1159/000209285.
    1. Demir N, Peker E, Gulsen I, Agengin K, Tuncer O. Factors affecting infection development after meningomyelocele repair in newborns and the efficacy of antibiotic prophylaxis. Childs Nerv Syst. 2015;31:1355–1359. doi:10.1007/s00381-015-2701-y.
    1. Kobraei EM, Ricci JA, Vasconez HC, Rinker BD. A comparison of techniques for myelomeningocele defect closure in the neonatal period. Childs Nerv Syst. 2014;30(9):1535–1541. doi:10.1007/s00381-014-2430-7.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner